Use of milvexian in the treatment and prevention of thrombotic conditions in patients with cardiovascular or cerebrovascular disease

A method of treating or preventing a thrombotic condition in a human patient with a cardiovascular or cerebrovascular disease, wherein the method comprises administering to the human patient an immediate release tablet comprising 25 mg, 50 mg, or 100 mg of milvexian (or a pharmaceutically acceptable salt or solvate thereof), and a pharmaceutically acceptable excipient, optionally the immediate release tablet is administered together with an antiplatelet therapy, wherein the immediate release tablet is administered twice daily.